It has been postulated that
latter plasma renin activity was raised compared to that in control subjects (median 19*8, range 1.04-41.7 and 2*86, 1-87-5-9 pmolIh respectively, p<002). Plasma aldosterone concentration was also raised in patients (2176, 199-6894 pmol/l compared to 368, 133-578 pmol/l in control subjects, p<001). Haemodialysis induced changes in circulating h-ANF which correlated with volume and right atrial pressure changes (p<0001 and p<O0O5 respectively). In six patients with no or mild renal failure infusion of 900 ml 5% human albumin solution caused a significant increase in plasma h-ANF (p<0.05) without natriuresis or diuresis, a finding compatible with the hypothesis that there may be resistance to h-ANF in this group. The present findings indicate that there is no deficiency ofh-ANF in fulminant hepatic failure and that known mechanisms of h-ANF release are not impaired.
Volume homoeostasis is frequently impaired in patients with fulminant hepatic failure, with sodium retention and an altered haemodynamic state of high cardiac output and a low systemic vascular resistance.' 2 Bernadi et al reported high plasma renin and aldosterone concentrations in fulminant hepatic failure and no correlation between plasma aldosterone concentration and renal sodium excretion.3 It has been postulated that a deficiency of a putative circulating natriuretic factor, or resistance to such a factor, may contribute to the sodium retention.4 Human atrial natriuretic factor (h-ANF) has been identified as a natriuretic and diuretic substance which suppresses the activity of the reninaldosterone system.' It is secreted by the cardiac atria in response to rises in atrial pressure, through atrial wall stretch, and thus seems to have a role in blood volume regulation.6"
Changes of plasma h-ANF concentration within the physiological range are now known to produce characteristic renal and humoral effects of this substance in humans. '2 The aim of the present study was to measure concentrations of h-ANF in fulminant hepatic failure and to examine its possible relation to the renin-aldosterone system. This relation was further examined by investigating the response of the above factors to fluid volume and right atrial pressure changes, induced by haemodialysis and by the infusion of 5% human albumin solution.
Patients and methods Thirty eight patients, 18 men and 20 women (age range years) with fulminant hepatic failure (development of encephalopathy within eight weeks of the onset of hepatic symptoms, in the absence of underlying liver disease) from paracetamol overdose were studied. Patients were excluded if (a) there was a past history of heart disease or arrhythmias; (b) they were receiving inotropic support; (c) the mean arterial pressure was less than 60 mmHg; (d) there was a greater than 15% change in pulse rate, mean arterial pressure, or right atrial pressure on three occasions one hour apart in the three hours before study; (e) there was rapidly changing coma grade'3 in the three hours before study or there were any clinical signs of cerebral oedema during the preceding 24 hours; (f) there was evidence of haemorrhage.
The patients were allocated to one of the following three groups; group 1 (12 patients) comprised patients with no or only mild renal impairment, defined as plasma creatinine <300 inol/l and urine output >600 ml/24 hours or 300 ml/12 h. Group 2 consisted of 21 patients with severe renal failure, defined as plasma creatinine >300 itmol/l and urine output <100 ml/day. Group 3 comprised five patients who were recovering from fulminant hepatic failure after a paracetamol overdose, with per- analysis.
The effect of plasma volume expansion was studied in six patients from group 1 who were being monitored by a pulmonary artery flotation catheter. Patients with a low right atrial pressure (s-2 mmHg) and pulmonary capillary wedge pressure (-5 mmHg) for more than 30 minutes received an infusion of 900 ml ofhuman albumin solution over a period of 40 minutes, to a maximum right atrial pressure of 5-6 mmHg or pulmonary capillary wedge pressure of 10-12 mmHg. Venous blood samples were taken just before and 40 minutes after the end of the infusion. Urine was collected for the hour preceding the infusion and for an hour after the albumin infusion was completed for measurement ofurine volume and sodium concentration.
ASSAYS
All samples for h-ANF were assayed in a single assay run by a sensitive radioimmunoassay after plasma extraction, as previously described.'214 Assay sensitivity was 1 pmol/l and intra-assay 
Results
There was no difference between h-ANF concentration in control subjects and patients with no or mild renal failure (group 1) (2'0-9'0, median 4'15 and 1-28-6, median 6'1 pmol/l respectively). Concentrations were higher in patients with severe renal failure (group 2) when compared to control subjects or patients with no or mild renal failure (median 10 1, 1-25 pmol/l, p<0001, Fig 1) . Values for right atrial pressure were similar in groups 1 and 2 (Table II) . In group 3, predialysis h-ANF levels were even higher (1 1-53'2, median 31-5 pmol/l) when compared to those in control subjects (p<0003).
There was a positive correlation between h-ANF and right atrial pressure levels (R=0'67, p<0 02) within group 1, but not within group 2 predialysis. In group 1, h-ANF levels correlated weaklywith plasma creatinine (R=0'6, p<OOS). There was a positive correlation for pooled values of plasma h-ANF and creatinine for groups 1, 2, and 3 (R=050, p<0 002). There was no correlation between h-ANF and mean arterial pressure in any group.
Plasma renin activity tended to be higher in all patient groups compared to controls, although statistical significance was not reached for group 1 (005<p<O 1) (Table II) . There was an inverse correlation between plasma renin activity and mean arterial pressure in patients in group 1 (R= -0-78, p<001, Fig 2) , but not in group 2.
Aldosterone concentrations were raised in all patient groups compared to controls (Table II) There was an inverse correlation between aldosterone and mean arterial pressure levels in group 1 (R=-0'73, p<0 02, Fig 2) , but not in group 2. There was a strong correlation between plasma renin activity and aldosterone concentration for combined values from all patient groups (R=0'978, p<0 0001). Serum sodium was lower in all three groups of patients compared to control subjects (Table I) .
Urine samples were available from only six patients in group 2 at 0900 hours, collected over periods ranging from 2-24 hours (total urine volume 5-80 ml). Median urine sodium excretion in these was 0'17 mmol/h (range 0 06-0'90 mmollh). Urine was available from all 12 patients in group 1. Baseline urine sodium excretion was median 0-22 mmol/h (range 0'06-6'46 mmol/h). The distribution was skewed: in 10 of the 12 patients urine sodium was less than 0'4 mmol/h, in one 0-9 mmol/h, and in the remaining patient 6 volume changes at completion ranged from -1'35 to + 10 litres, and change in right atrial pressure was -9 5 to +6-0 mmHg. Median plasma h-ANF levels before and after dialysis were 9-67 pmol/l (range 1-28 6) and 11L75 pmol/l (range 1-28 4) respectively. There was a positive correlation between change in right atrial pressure with change in h-ANF (Fig 3A) and between volume change and change in h-ANF (Fig 3B) . Although plasma renin activity and aldosterone concentrations were decreased after dialysis (median 23 8 to 18X3 pmol/ml/h and 3621 to 2295 pmol/l respectively, p<003), these changes did not correlate with fluid volume or change in right atrial pressure.
Response to albumin infusion. Preinfusion plasma renin activity and aldosterone concentration were appreciably above the normal range (Tables II and III) . Packed cell volume dropped significantly after albumin infusion (median 40%, range 28-44%, to 37%, range 27-40%, p<0O05). There was a significant rise in right atrial pressure (p<005) and plasma h-ANF concentration (p<005), with a corresponding decrease in plasma renin activity (p<005 , Table III) . Aldosterone concentration dropped in five patients and rose in one (not significant) and there was no change in urine volume or sodium excretion (Table III) . Urine microscopy of preinfusion samples showed no casts in any ofthe six samples. Urine/plasma osmolality ratio was less than 1 09 in two cases and greater than 1 1 in four.
Discussion
Studies of the renin-aldosterone system and of electrolyte and water balance are usually carried out after several days on a controlled sodium and potassium intake. Because of the rapid changes in the clinical condition of patients with fulminant hepatic failure it is not possible to do this. Saline infusion is avoided in these patients because of their tendency to retain sodium. For this reason patients are compared to healthy control subjects on severe sodium restriction. Although the criteria for inclusion were such that only relatively stable patients were entered, these limitations must be considered when interpreting the present results. Since patients did not receive saline for 24 hours before the study, it would be difficult to identify those with inappropriate sodium retention on the basis of urine sodium excretion alone. Therefore the 'dynamic' test of volume expansion was used in six patients who were not oliguric (group 1). Although specific tests to assess renal tubular function (urine acidification and excretion of amino acids and tubular proteins) were not performed in these six cases, the absence of casts in the urine suggests that acute tubular necrosis was not present at the time of study. The separation of patients into those with no mild renal failure and severe renal failure according to plasma creatinine and urine volume was empirical and was based on findings from a previous study by Wilkinson et all in order to study patients at two ends of a continuous spectrum of renal impairment. In another study of paracetamol induced fulminant hepatic failure with renal failure Wilkinson et all7 reported that functional renal failure was present in about a third of cases, prerenal uraemia in 10-15%, and direct renal toxicity due to paracetamol causing acute tubular The results show that there is no deficiency of h-ANF in fulminant hepatic failure. In the presence ofno or mild renal failure, basal h-ANF levels were similar to those in control subjects, but in patients who had developed severe renal failure they were raised. In patients recovering from fulminant hepatic failure with persisting severe renal failure h-ANF levels were even higher. These findings, along with the correlation of h-ANF to plasma creatinine concentration, suggest that the raised levels of h-ANF in fulminant hepatic failure are related to the presence of renal failure. The finding of similar right atrial pressure values in groups 1 and 2 would be compatible with the hypothesis that in the presence of renal failure factors other than increased atrial distension may be contributing to the raised levels of h-ANF, although it is possible that atrial volume may increase without a rise in atrial pressure. The importance of the kidney in the clearance of circulating h-ANF has been shown in previous studies of adults undergoing cardiac catheterisation, where there was significant extraction of circulating h-ANF by this organ,'8 and by receptor-distribution'9 and h-ANF clearance'9-2' studies in animals. In the canine model, extraction of ANF by the kidney has been shown to be largely dependent on glomerular filtration rate." Pronounced renal vasoconstriction with reduced glomerular filtration rate is common in fulminant hepatic failure,2' and thus may contribute to reduced extraction of h-ANF.
Basal aldosterone concentrations and plasma renin activity was raised in all patient groups,2223 although statistical significance was not reached in the case of those with mild renal impairment. In all groups aldosterone concentrations correlated well with plasma renin activity, suggesting that renin remains the major determinant of aldosterone concentrations in fulminant hepatic failure.24 In the absence of severe renal failure, plasma renin activity and aldosterone concentrations were inversely proportional to mean arterial pressure, supporting previous observations which suggested that stimulation of the reninaldosterone system may be a homoeostatic response to hypotension. 3 The correlation of changes in h-ANF with 
